Vaccination with Rev and Tat against AIDS

Vaccine

Volumn 17, Issue 20-21, 1999, Pages 2713-2714

  Osterhaus, A D M E ^a   Van Baalen, C A ^a   Gruters, R A ^a,b   Schutten, M ^a   Siebelink, C H J ^a   Hulskotte, E G J ^a   Tijhaar, E J ^a,c   Randall, R E R ^c   Van Amerongen, G ^a   Fleuchaus, A ^d   Erfle, V ^d   Sutter, G ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; REV PROTEIN; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DRUG SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; GENE PRODUCTS, REV; GENE PRODUCTS, TAT; HUMANS; MACACA FASCICULARIS; PILOT PROJECTS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0033523064     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00498-8     Document Type: Article

References (8)

1. Graham B.S., McElrath M.J., Connor R.I., et al. J Infect Dis. 177:1998;310-319.
2. Moore J.P., McKeating J.A., Huang Y.X., Ashkenazi A., Ho D.D. J Virol. 66:1992;235-243.
3. Letvin N.L. Science. 280:1998;1875-1880.
4. Gauduin M.C., Parren P.W., Weir R., Barbas C.F., Burton D.R., Koup R.A. Nat Med. 3:1997;1389-1393.
5. Conley A.J., Kessler J.A. II, Boots L.J., et al. J Virol. 70:1996;6751-6758.
6. Van Baalen C.A., Schutten M., Huisman R.C., Boers P.H., Gruters R.A., Osterhaus A.D. J Virol. 72:1998;6851-6857.
7. Van Baalen C.A., Pontesilli O., Huisman R.C., et al. J Gen Virol. 78:1997;1913-1918.
8. Hulskotte E.G., Geretti A.M., Siebelink K.H., et al. J Virol. 69:1995;6289-6296.